Antibodies Primary

ALK (Anaplastic Lymphoma Kinase) Polyclonal Antibody

NEW
ALK (Anaplastic Lymphoma Kinase) Polyclonal Antibody

Article No

JM-3355-100

Application

WB

Species Reactivity

human

Size

100 µg

Source / Host

rabbit

Shipping Information

4°C

Product insert

Suggested protocols

Specifications

Application WB
Article No JM-3355-100
Country Availability SE, FI, DK, NO, IS, EE, LV, LT, FO, GL, RU
Clone Type polyclonal
Concentration 0.5 mg/ml
Conjugation Unconjugated
Description ALK (Anaplastic Lymphoma Kinase) Polyclonal Antibody
Supplier MBL International Corp.
Isotype IgG
Notes ALK (anaplastic lymphoma kinase) was originally discovered as a NPM (Nucleophosmin)-ALK fusion protein. The NPM-ALK is a constitutively active oncogenic tyrosine kinase associated with anaplastic lymphoma. Activation of PLCgamma by NPM-ALK has been sμggested as a crucial step for this lymphoma-associated oncogenic tyrosine kinase.
Alias Names ALK tyrosine kinase receptor (EC 2.7.10.1), Anaplastic lymphoma kinase, CD antigen CD246
Product Type Antibodies Primary
Shipping Information 4°C
Size 100 µg
Source / Host rabbit
Species Reactivity human
Storage -20°C
Technical Specifications ALK (anaplastic lymphoma kinase) was originally discovered as a NPM (Nucleophosmin)-ALK fusion protein. The NPM-ALK is a constitutively active oncogenic tyrosine kinase associated with anaplastic lymphoma. Activation of PLCgamma by NPM-ALK has been sμggested as a crucial step for this lymphoma-associated oncogenic tyrosine kinase.
Product Page Updated 2020-06-10T09:56:05.519Z

Shipping info

The delivery time for this item is approximately 8-15 business days. If other deviations occur, this will be noted on the order confirmation or communicated via email. Please note, we do reserve the right to select the best packaging and shipping method in order to insure the stability of the product and allow efficient order tracking.